Skip to main content
Top
Published in: Indian Journal of Gastroenterology 5/2017

01-09-2017 | Original Article

Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India

Authors: Deepu David, Anantharam Raghavendran, Ashish Goel, C. Bharath Kumar, Thomas Alex Kodiatte, Deepak Burad, Priya Abraham, Banumathi Ramakrishna, Philip Joseph, Jeyamani Ramachandran, C. E. Eapen

Published in: Indian Journal of Gastroenterology | Issue 5/2017

Login to get access

Abstract

Aim of the study

The aim of the study was to analyze the prevalence of risk factors for non-alcoholic fatty liver disease (NAFLD) in patients with non-B non-C hepatocellular carcinoma (HCC).

Methods

Between June 2012 and November 2014, patients with HCC, negative for hepatitis B surface antigen and hepatitis C virus antibody, were included in this study. All patients were assessed for risk factors for NAFLD such as diabetes mellitus (DM), hypertension, dyslipidemia, metabolic syndrome, and obesity.

Results

Forty-seven patients with non-B non-C HCC (males, 37; age, 60±10 years; mean±SD) were studied. Model for end-stage liver disease score was 11±4. Twenty-five patients were in Child’s class A. History of significant alcohol intake was noted in 11 (23%) patients. Prevalence of risk factors for NAFLD were obesity 24 (51%), DM 22 (47%), metabolic syndrome 21 (45%), hypertension 16 (34%), and dyslipidemia 13 (28%). Forty (85%) patients had at least one risk factor for NAFLD. The mean duration of at least one NAFLD risk factor was 7.5 years, prior to diagnosis of HCC. Thirteen (28%) patients were positive for anti-HBc; however, none of the study patients had detectable HBV DNA in blood.

Conclusions

Eighty-five percent of the patients with non-B non-C HCC had at least one risk factor for NAFLD. None of the study patients had occult hepatitis B infection. NAFLD is emerging as the major etiological contributing factor for non-B non-C HCC in India.
Literature
1.
go back to reference Fang Y, Shang QL, Liu JY, et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Inf Secur. 2009;58:383–8. Fang Y, Shang QL, Liu JY, et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Inf Secur. 2009;58:383–8.
2.
3.
6.
go back to reference Kannangai R, Molmenti E, Arrazola L, et al. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat. 2004;11:297–301.CrossRefPubMed Kannangai R, Molmenti E, Arrazola L, et al. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat. 2004;11:297–301.CrossRefPubMed
7.
go back to reference Hatanaka K, Kudo M, Fukunaga T, et al. Clinical characteristics of nonBnonC- HCC: comparison with HBV and HCV related HCC. Intervirology. 2007;50:24–31.CrossRefPubMed Hatanaka K, Kudo M, Fukunaga T, et al. Clinical characteristics of nonBnonC- HCC: comparison with HBV and HCV related HCC. Intervirology. 2007;50:24–31.CrossRefPubMed
8.
go back to reference Kim MJ, Kwon OS, Chung NS, et al. The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis. Korean J Hepatol. 2008;14:67–76.CrossRefPubMed Kim MJ, Kwon OS, Chung NS, et al. The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis. Korean J Hepatol. 2008;14:67–76.CrossRefPubMed
9.
go back to reference Unnikrishnan R, Anjana RM, Mohan V. Diabetes mellitus and its complications in India. Nat Rev Endocrinol. 2016;12:357–70.PubMed Unnikrishnan R, Anjana RM, Mohan V. Diabetes mellitus and its complications in India. Nat Rev Endocrinol. 2016;12:357–70.PubMed
10.
go back to reference Jain SR, Shah KH, Acharya HN, Barot K, Sharma KH. Prevalence and predictors of metabolic syndrome in young asymptomatic Gujarati population. Int J Chronic Dis. 2015;2015:365217.PubMedPubMedCentral Jain SR, Shah KH, Acharya HN, Barot K, Sharma KH. Prevalence and predictors of metabolic syndrome in young asymptomatic Gujarati population. Int J Chronic Dis. 2015;2015:365217.PubMedPubMedCentral
11.
go back to reference Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Impact of the Gather mHealth system on A1C: primary results of a multisite randomized clinical trial among people with type 2 diabetes in India. Diabetes Care. 2016;39:e169–70.CrossRefPubMed Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Impact of the Gather mHealth system on A1C: primary results of a multisite randomized clinical trial among people with type 2 diabetes in India. Diabetes Care. 2016;39:e169–70.CrossRefPubMed
12.
go back to reference Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788–93.CrossRefPubMed Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788–93.CrossRefPubMed
14.
go back to reference Oommen AM, Abraham VJ, George K, Jose VJ. Prevalence of risk factors for non-communicable diseases in rural & urban Tamil Nadu. Indian J Med Res. 2017;144:460–71.CrossRef Oommen AM, Abraham VJ, George K, Jose VJ. Prevalence of risk factors for non-communicable diseases in rural & urban Tamil Nadu. Indian J Med Res. 2017;144:460–71.CrossRef
15.
go back to reference Pradeepa R, Anjana RM, Joshi SR, et al. Prevalence of generalized & abdominal obesity in urban & rural India—the ICMR-INDIAB study (Phase-I) [ICMR-NDIAB-3]. Indian J Med Res. 2015;142:139–50.CrossRefPubMedPubMedCentral Pradeepa R, Anjana RM, Joshi SR, et al. Prevalence of generalized & abdominal obesity in urban & rural India—the ICMR-INDIAB study (Phase-I) [ICMR-NDIAB-3]. Indian J Med Res. 2015;142:139–50.CrossRefPubMedPubMedCentral
17.
go back to reference EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012:56:908–43. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012:56:908–43.
18.
go back to reference National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.
19.
go back to reference Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163–70.PubMed Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163–70.PubMed
20.
go back to reference Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases practice guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–3.CrossRefPubMed Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases practice guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–3.CrossRefPubMed
21.
go back to reference Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652–7.CrossRefPubMed Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652–7.CrossRefPubMed
22.
go back to reference O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol. 2009;105:14–32. quiz 3CrossRefPubMed O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol. 2009;105:14–32. quiz 3CrossRefPubMed
23.
go back to reference Pal S, Ramachandran J, Kurien RT, et al. Hepatocellular carcinoma continues to be diagnosed in the advanced stage: profile of hepatocellular carcinoma in a tertiary care hospital in South India. Trop Dr. 2013;43:25–6. Pal S, Ramachandran J, Kurien RT, et al. Hepatocellular carcinoma continues to be diagnosed in the advanced stage: profile of hepatocellular carcinoma in a tertiary care hospital in South India. Trop Dr. 2013;43:25–6.
24.
go back to reference Paul SB, Chalamalasetty SB, Vishnubhatla S, et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77:162–71.CrossRefPubMed Paul SB, Chalamalasetty SB, Vishnubhatla S, et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77:162–71.CrossRefPubMed
25.
go back to reference Sarma MP, Asim M, Medhi S, Bharathi T, Diwan R, Kar P. Viral genotypes and associated risk factors of hepatocellular carcinoma in India. Cancer Biol Med. 2012;9:172–81.PubMedPubMedCentral Sarma MP, Asim M, Medhi S, Bharathi T, Diwan R, Kar P. Viral genotypes and associated risk factors of hepatocellular carcinoma in India. Cancer Biol Med. 2012;9:172–81.PubMedPubMedCentral
26.
go back to reference Sarin SK, Thakur V, Guptan RC, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol. 2001;16:666–73.CrossRefPubMed Sarin SK, Thakur V, Guptan RC, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol. 2001;16:666–73.CrossRefPubMed
27.
go back to reference Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y. Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol. 2008;43:967–74.CrossRefPubMed Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y. Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol. 2008;43:967–74.CrossRefPubMed
28.
go back to reference Utsunomiya T, Shimada M, Kudo M, et al. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg. 2013;259:336–45.CrossRef Utsunomiya T, Shimada M, Kudo M, et al. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg. 2013;259:336–45.CrossRef
29.
go back to reference Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–40.CrossRefPubMed Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–40.CrossRefPubMed
30.
go back to reference Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349–54.CrossRefPubMed Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349–54.CrossRefPubMed
31.
go back to reference Baffy G. Hepatocellular carcinoma in non-alcoholic fatty liver disease: epidemiology, pathogenesis, and prevention. J Clin Transl Hepatol. 2013;1:131–7.PubMedPubMedCentral Baffy G. Hepatocellular carcinoma in non-alcoholic fatty liver disease: epidemiology, pathogenesis, and prevention. J Clin Transl Hepatol. 2013;1:131–7.PubMedPubMedCentral
32.
go back to reference Kaneda K, Kubo S, Tanaka H, et al. Features and outcome after liver resection for non-B non-C hepatocellular carcinoma. Hepatogastroenterology. 2012;59:1889–92.PubMed Kaneda K, Kubo S, Tanaka H, et al. Features and outcome after liver resection for non-B non-C hepatocellular carcinoma. Hepatogastroenterology. 2012;59:1889–92.PubMed
33.
go back to reference Pattnaik K, Bhuyan P, Mahapatra S, Mishra B, Kar S, Singh SP. Analysis of risk factors for fibrosis in biopsy proven NAFLD. J Clin Exp Hepatol. 2015;3:S27.CrossRef Pattnaik K, Bhuyan P, Mahapatra S, Mishra B, Kar S, Singh SP. Analysis of risk factors for fibrosis in biopsy proven NAFLD. J Clin Exp Hepatol. 2015;3:S27.CrossRef
34.
go back to reference Jain D, Nayak NC, Kumaran V, Saigal S. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India. Arch Pathol Lab Med. 2013;137:961–6.CrossRefPubMed Jain D, Nayak NC, Kumaran V, Saigal S. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India. Arch Pathol Lab Med. 2013;137:961–6.CrossRefPubMed
35.
go back to reference Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM. 2008;101:479–85.CrossRefPubMed Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM. 2008;101:479–85.CrossRefPubMed
36.
go back to reference Singh SV, Goyal SK, Chowdhury BL. Primary carcinoma of liver in Udaipur. J Assoc Physicians India. 1971;19:693–5.PubMed Singh SV, Goyal SK, Chowdhury BL. Primary carcinoma of liver in Udaipur. J Assoc Physicians India. 1971;19:693–5.PubMed
37.
go back to reference Yotsuyanagi H, Shintani Y, Moriya K, et al. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis. 2000;181:1920–8.CrossRefPubMed Yotsuyanagi H, Shintani Y, Moriya K, et al. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis. 2000;181:1920–8.CrossRefPubMed
38.
go back to reference Rizvi M, Azam M, Sultan A, et al. Prevalence of genotype D in chronic liver disease patients with occult HBV infection in northern region of India. Indian J Pathol Microbiol. 2014;57:537–41.CrossRefPubMed Rizvi M, Azam M, Sultan A, et al. Prevalence of genotype D in chronic liver disease patients with occult HBV infection in northern region of India. Indian J Pathol Microbiol. 2014;57:537–41.CrossRefPubMed
39.
go back to reference Ismail AM, Devakumar S, Anantharam R, et al. Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India. Blood Transfus. 2011;10:230–2.PubMed Ismail AM, Devakumar S, Anantharam R, et al. Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India. Blood Transfus. 2011;10:230–2.PubMed
40.
go back to reference Radhakrishnan S, Abraham P, Raghuraman S, et al. Infrequent occurrence of silent HBV infection among Indian patients with chronic liver disease. Indian J Gastroenterol. 2001;20:87–9.PubMed Radhakrishnan S, Abraham P, Raghuraman S, et al. Infrequent occurrence of silent HBV infection among Indian patients with chronic liver disease. Indian J Gastroenterol. 2001;20:87–9.PubMed
Metadata
Title
Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India
Authors
Deepu David
Anantharam Raghavendran
Ashish Goel
C. Bharath Kumar
Thomas Alex Kodiatte
Deepak Burad
Priya Abraham
Banumathi Ramakrishna
Philip Joseph
Jeyamani Ramachandran
C. E. Eapen
Publication date
01-09-2017
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 5/2017
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-017-0785-x

Other articles of this Issue 5/2017

Indian Journal of Gastroenterology 5/2017 Go to the issue